Ovarian Cancer Clinical Trials in Baltimore

Showing 261-274 of 274 trials

A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

NCT00516841

To evaluate the efficacy of voloxicimab when administered at 15 mg/kg qwk in subjects with platinum-resistant, advanced epithelial ovarian cancer or primary peritoneal cancer.

Ovarian CancerPeritoneal Neoplasms

Facet Biotech16 participantsStarted Aug 2007

Los Angeles, California, United States • Orange, California, United States • San Diego, California, United States +20 more locations

TERMINATEDPhase 2< 1 mile

Study of XL999 in Patients With Previously Treated Ovarian Cancer

NCT00277290

This clinical trial is being conducted at multiple sites to evaluate the activity, safety, and tolerability of XL999 when given weekly to patients with ovarian cancer that has previously been treated with platinum-based chemotherapy. XL999 is a small molecule inhibitor of multiple kinases including VEGFR, PDGFR, FGFR, FLT-3, and Src, which are involved in tumor cell growth, formation of new blood vessels (angiogenesis), and metastasis.

Ovarian Cancer

Symphony Evolution, Inc.24 participantsStarted Jan 2006

Greenbrae, California, United States • Port Saint Lucie, Florida, United States • Chicago, Illinois, United States +6 more locations

A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

Study of XL999 in Patients With Previously Treated Ovarian Cancer

Ovarian Cancer Trials in Other Cities

Clinical Trial for Ovarian Cancer (OvaRex®)

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Vinorelbine and XR9576 to Treat Cancer

SU5416 and Carboplatin to Treat Ovarian Cancer

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Other Conditions in Baltimore